Strizki, J. M., Gaspar, J. M., Howe, J. A., Hutchins, B., Mohri, H., Nair, M. S., Kinek, K. C., McKenna, P., Goh, S. L., & Murgolo, N. (2024). Molnupiravir maintains antiviral activity against SARS-CoV-2 variants and exhibits a high barrier to the development of resistance. Antimicrobial Agents and Chemotherapy, 68(1). https://doi.org/10.1128/aac.00953-23
Columbia Affiliation:
Subjects:
SARS-CoV-2
(MeSH)
COVID-19
(MeSH)
Coronavirus Disease 2019 Research
(OpenAlex Topic)
Viral RNA Silencing and Plant Immunity
(OpenAlex Topic)
Epidemiology and Pathogenesis of Respiratory Viral Infections
(OpenAlex Topic)
Publication Type:
Article
Unique ID:
10.1128/aac.00953-23
PMID:
DOI:
Publication Date:
Data Source:
OpenAlex
Source Link: